Glycated hemoglobin and outcomes of heart failure (get-with-the-guidelines–heart failure)
Echouffo-Tcheugui JB, Sheng S, DeVore AD, et al.
American Journal of Cardiology. Published online, 3 December 2018
Leggi
Annali AMD 2018 – Diabete, obesità e malattia cardiovascolare
La disponibilità negli ultimi anni di nuovi farmaci innovativi appartenenti alla classe degli inibitori del co-trasportatore di sodio glucosio 2 (SGLT2i) e degli agonisti recettoriali del glucagon-like peptide (GLP-1 RA) ha dimostrato evidenti benefici cardiovascolari nei pazienti affetti da diabete, con una conseguente riduzione dell’impatto clinico, sociale ed economico delle…
Leggi
AIFA – Biosimilari: prove di efficacia e real-world data ne confermano l’intercambiabilità
13/12/2018
Leggi
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Svanström H, Ueda P, Melbye M, et al.
The Lancet Diabetes and Endocrinology. Published online, 5 December 2018
Leggi
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
Abrahami D, Douros A, Yin H, et al.
BMJ. 2018;363:k4880
Leggi
GLP-1 receptor agonists and cardiovascular risk in routine clinical practice
Schernthaner G, Schernthaner-Reiter MH
The Lancet Diabetes and Endocrinology. Published online, 5 December 2018
Leggi
Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial
Dodd JM, Louise J, Deussen AR, et al.
The Lancet Diabetes and Endocrinology. Published online, 4 December 2018
Leggi
Trajectories of childhood BMI and adult diabetes: the Bogalusa Heart Study
Zhang T, Xu J, Li S, et al.
Diabetologia. 2019;62(1):70-7
Leggi
Global trends in diabetes complications: a review of current evidence
Harding JL, Pavkov ME, Magliano DJ, et al.
Diabetologia. 2019;62(1):3-16
Leggi
A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study
Gæde J, Oellgaard J, Ibsen R, et al.
Diabetologia. 2019,62(1):147-55
Leggi